Description
PRIME TRESTOLONE A 50 – Trestolone Acetate 50mg/ml
PRIME TRESTOLONE A 50 delivers Trestolone Acetate (MENT), one of the most potent anabolic agents available today. Known for its powerful muscle-building capacity and unique endocrine profile, this compound is reserved for highly experienced users aiming to maximize mass gains within a short timeframe.
Mechanism of Action:
Trestolone acts as both a potent androgen receptor agonist and a progestin. Unlike testosterone, it does not require conversion to DHT to exert anabolic effects and does not bind significantly to SHBG, resulting in high bioavailability. Its structure also resists aromatization to estradiol, instead converting to 7α-methyl-estradiol, a less active metabolite.
Use Case:
Recommended only for short, high-impact bulking cycles where rapid strength and size gains are prioritized. Due to its impact on the HPTA and potential estrogenic activity, it should be used in well-structured cycles with proper ancillary compounds and recovery planning.
Advantages of High-Concentration Format:
At 50mg/ml, PRIME TRESTOLONE A 50 provides better control of dosing in a compound that requires precise titration due to its intensity. The low-volume format enables accurate, scalable administration for short cycles or experimental phases.
All products sold by ORYVION are intended for laboratory research purposes only and are not approved for human consumption, medical use, or veterinary applications. These compounds are not classified as dietary supplements or pharmaceuticals.
ORYVION operates strictly within the legal frameworks of the jurisdictions in which it conducts business. Sales are limited to countries and regions where the possession and use of research chemicals are permitted by law. It is the sole responsibility of the purchaser to ensure compliance with local, national, and international laws and regulations.
By purchasing, the customer affirms that they are at least 21 years of age, legally authorized to receive such materials, and fully aware of their intended use. ORYVION disclaims all liability for misuse, improper handling, or any consequences resulting from non-compliant use of these products.
ORYVION complies with relevant provisions under EU’s Pharmaceutical and Medical Device Act, as well as applicable international guidelines regarding non-pharmaceutical research compounds.